Tag: Dr. Crystal Qin

LaNova Medicines, AstraZeneca sign $600m worth licensing deal for LM-305

businessnewstoday- May 14, 2023

LaNova Medicines has signed an exclusive license deal worth over $600 million for its pre-clinical stage antibody drug conjugate (ADC) called LM-305 with AstraZeneca. LM-305 ... Read More